176 related articles for article (PubMed ID: 6735997)
1. Tyramine studies and the safety of MAOI drugs.
Simpson GM; White K
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):59-61. PubMed ID: 6735997
[TBL] [Abstract][Full Text] [Related]
2. Tyramine and new monoamine oxidase inhibitor drugs.
Simpson GM; de Leon J
Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
[TBL] [Abstract][Full Text] [Related]
3. The combined use of MAOIs and tricyclics.
White K; Simpson G
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):67-9. PubMed ID: 6376486
[TBL] [Abstract][Full Text] [Related]
4. The monoamine oxidase inhibitor-tyramine interaction.
Brown C; Taniguchi G; Yip K
J Clin Pharmacol; 1989 Jun; 29(6):529-32. PubMed ID: 2666453
[TBL] [Abstract][Full Text] [Related]
5. Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors?
Pare CM; Kline N; Hallstrom C; Cooper TB
Lancet; 1982 Jul; 2(8291):183-6. PubMed ID: 6123888
[TBL] [Abstract][Full Text] [Related]
6. Patient compliance with MAO inhibitor therapy.
Walker JI; Davidson J; Zung WW
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-inhibiting antidepressants. A clinical update.
Murphy DL; Sunderland T; Cohen RM
Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
[TBL] [Abstract][Full Text] [Related]
8. Safer use of MAOIs.
Fier M
Am J Psychiatry; 1991 Mar; 148(3):391-2. PubMed ID: 1992846
[No Abstract] [Full Text] [Related]
9. Attempts to attenuate the 'cheese effect'. Combined drug therapy in depressive illness.
Pare CM; Al Mousawi M; Sandler M; Glover V
J Affect Disord; 1985 Sep; 9(2):137-41. PubMed ID: 2932486
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake.
Salter M; Kenney A
Cardiovasc Toxicol; 2018 Dec; 18(6):583-586. PubMed ID: 30083815
[TBL] [Abstract][Full Text] [Related]
11. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
Cooper AJ
Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
[TBL] [Abstract][Full Text] [Related]
12. Clarifying the safety of the MAOI diet and pizza.
Feinberg S; Holzer B
J Clin Psychiatry; 2000 Feb; 61(2):145-6. PubMed ID: 10732665
[No Abstract] [Full Text] [Related]
13. A clinical overview of monoamine oxidase inhibitors.
Zisook S
Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453
[No Abstract] [Full Text] [Related]
14. The transdermal delivery system of monoamine oxidase inhibitors.
VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
[TBL] [Abstract][Full Text] [Related]
15. On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.
Da Prada M; Zürcher G; Wüthrich I; Haefely WE
J Neural Transm Suppl; 1988; 26():31-56. PubMed ID: 3283290
[TBL] [Abstract][Full Text] [Related]
16. Practical aspects of MAO inhibitor therapy.
Davidson J; Zung WW; Walker JI
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):81-4. PubMed ID: 6735999
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase inhibitors--current status.
Zemishlany Z; Radwan M; Wijsenbeek H
Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
[No Abstract] [Full Text] [Related]
18. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
Tiller JW; Mitchell P; Burrows GD
Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
[No Abstract] [Full Text] [Related]
19. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
Bieck PR; Antonin KH; Schmidt E
Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
[TBL] [Abstract][Full Text] [Related]
20. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
Bieck PR
Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
